查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1679772

核酸萃取仪器和试剂市场报告：趋势、预测和竞争分析（至 2031 年）

Nucleic Acid Extraction Instrument and Reagent Market Report: Trends, Forecast and Competitive Analysis to 2031
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

全球核酸萃取仪器和试剂市场前景光明，在学术研究机构、医院和诊断中心、製药和生物技术以及受託研究机构市场都存在机会。预计全球核酸萃取设备和试剂市场在 2025 年至 2031 年期间的复合年增长率为 10.4%。该市场的主要驱动力是对个人化治疗的兴趣日益浓厚、慢性病发病率不断上升以及医学诊断技术的不断发展。

  • Lucintel 预测设备将成为所有类型中成长最快的。
  • 根据最终用途，预计学术研究机构将实现最高成长。
  • 按地区划分，预计北美将实现最高成长。

核酸萃取设备及试剂市场的策略性成长机会

由于技术进步和对高效诊断解决方案的需求不断增加，核酸萃取设备和试剂市场已具备成长的条件。公司可以利用多种策略机会来满足不断变化的市场需求，并将其业务范围扩展到医疗保健、研究和生物技术等各个领域。

  • 拓展新兴市场：随着新兴市场医疗基础设施的发展，对核酸萃取技术的需求日益增加。透过对这些地区进行策略性投资，公司可以提供适合当地需求的经济实惠且易于取得的解决方案。与当地分销商和医疗保健提供者建立伙伴关係有助于加强市场渗透并加速成长。
  • 开发客自订解决方案：客製化核酸萃取仪器和试剂以适应特定应用和用户需求具有巨大的成长潜力。透过与研究机构和临床实验室合作，製造商可以针对不同的样本类型和提取方法设计专门的产品，从而提高用户满意度和市场竞争力。
  • 人工智慧和机器学习的整合：将人工智慧 (AI) 和机器学习技术整合到核酸萃取过程中，为提高效率和准确性提供了机会。这些技术可以优化萃取通讯协定，提高产量并减少处理时间，对于寻求高效能解决方案的现代实验室来说，它们具有吸引力。
  • 关注个人化医疗：个人化医疗的兴起为核酸提取公司带来了独特的机会。由于基因组学在个人化医疗中发挥关键作用，对高品质核酸萃取的需求日益增加。开发支持基因组研究和精准医疗的强大解决方案可以使公司处于这个不断增长的市场的前沿。
  • 伙伴关係和协作：与生物技术、学术和诊断公司建立策略伙伴关係可以促进创新并扩大市场范围。这项合作研究将促进尖端萃取技术的发展，扩大核酸检测在癌症研究、感染疾病诊断、基因研究等多个领域的应用。

由于技术进步和全球需求的不断增长，核酸萃取设备和试剂市场提供了众多策略性成长机会。专注于新兴市场、客製化解决方案和人工智慧等创新技术可以帮助公司在竞争中取得成功。此外，合作与伙伴关係可以增强产品供应并扩大市场范围，确保公司能够充分满足医疗保健和研究领域不断变化的需求。随着市场的不断发展，抓住这些机会对于长期成长和创新至关重要。

核酸萃取仪器和试剂市场的驱动因素与挑战

核酸萃取仪器和试剂市场虽然受到推动其成长的各种因素的影响，但也面临企业必须克服的若干挑战。了解这些驱动因素对于寻求优化策略并利用这个快速发展的行业中的新机会相关人员。

推动核酸萃取仪器和试剂市场发展的因素包括：

  • 诊断测试的需求不断增加：诊断测试的需求不断增加：遗传感染疾病的日益普及增加了对准确诊断测试的需求。这一趋势推动了对可靠核酸萃取技术的需求，因为它们对于生产有效检测和治疗所需的高品质样本至关重要。
  • 生物技术的进步：生物技术的快速进步正在推动核酸萃取方法方法的创新。自动化系统和以微珠为基础的萃取等新技术正在提高效率和可靠性。这些创新不仅改善了实验室工作流程，而且还满足了研究人员和临床医生对高通量解决方案日益增长的需求。
  • 增加对基因组学的投资：基因组学研究投资的激增推动了对核酸萃取设备和试剂的需求。随着越来越多的机构转向基因组学进行个人化医疗和药物开发，对先进提取技术的需求变得越来越重要，为市场相关人员提供了巨大的成长机会。
  • 分子诊断的监管支持：分子诊断的支持性法律规范正在推动市场成长。政府和监管机构正在鼓励开发和采用基于核酸的检测方法，进一步刺激对符合严格品质标准的萃取技术和试剂的需求。
  • 个人化医疗意识的增强：个人化医疗意识和实践的增强正在产生对先进核酸提取解决方案的需求。随着医疗保健转向基于基因资讯的个人化治疗，对高效、准确的提取方法的需求变得至关重要，从而推动了市场的扩张。

核酸萃取仪器及试剂市场的挑战如下：

  • 先进技术高成本：核酸萃取市场面临的关键挑战之一是先进技术和自动化系统成本高。新兴市场的小型实验室和设施可能难以投资这种昂贵的设备，这限制了它们获得高效萃取方法的机会。
  • 监管障碍：核酸萃取市场必须应对复杂的法规环境，这可能会延迟新产品的核准和商业化。遵守严格的品质和安全标准需要大量的资源和时间，这对试图快速将创新解决方案推向市场的公司来说是一个挑战。
  • 竞争与市场饱和：随着核酸萃取技术的需求增加，市场竞争日益激烈。许多公司已经进入该领域，该领域可能会趋于饱和。为了保持市场占有率并满足不断变化的客户需求，公司必须提供差异化的产品并不断创新。

受技术进步和诊断测试需求不断增长的推动，核酸萃取设备和试剂市场充满机会。儘管存在高成本、监管障碍和竞争等挑战，但公司可以透过策略性地应对这些挑战来取得成功。透过利用成长动力并有效克服挑战，相关人员可以利用医疗保健和研究领域不断变化的需求，为在这个充满活力的市场中取得长期成功做好准备。

目录

第一章执行摘要

第二章全球核酸萃取仪器与试剂市场：市场动态

  • 简介、背景和分类
  • 供应链
  • 产业驱动力与挑战

第三章市场趋势与预测分析（2019-2031）

  • 宏观经济趋势（2019-2024）及预测（2025-2031）
  • 全球核酸萃取仪器及试剂市场趋势（2019-2024）及预测（2025-2031）
  • 全球核酸萃取仪器和试剂市场（按类型）
    • 装置
    • 旋转柱
    • 珠子/磁珠
    • 自动化核酸萃取系统
    • 萃取试剂套件、试剂和耗材
    • 其他的
  • 全球核酸萃取仪器和试剂市场（按萃取类型）
    • DNA萃取
    • DNA/RNA萃取
    • RNA萃取
  • 全球核酸萃取仪器和试剂市场（依方法）
    • 基于解决方案的方法
    • 基于固相的方法
  • 全球核酸萃取设备和试剂市场（按最终用途）
    • 学术研究所
    • 医院和诊断中心
    • 製药和生物技术
    • CRO（委外研发机构）
    • 其他的

第四章区域市场趋势与预测分析（2019-2031）

  • 全球核酸萃取仪器及试剂市场（按地区）
  • 北美核酸萃取设备及试剂市场
  • 欧洲核酸萃取设备及试剂市场
  • 亚太核酸萃取设备及试剂市场
  • 其他地区核酸萃取设备及试剂市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 全球核酸萃取仪器和试剂市场成长机会（按类型）
    • 全球核酸萃取仪器和试剂市场按萃取类型分類的成长机会
    • 全球核酸萃取仪器和试剂市场成长机会（按方法）
    • 全球核酸萃取仪器和试剂市场的成长机会（以最终用途）
    • 核酸萃取设备及试剂市场全球各区域成长机会
  • 全球核酸萃取设备及试剂市场新趋势
  • 战略分析
    • 新产品开发
    • 全球核酸萃取设备及试剂市场产能扩张
    • 全球核酸萃取仪器和试剂市场的企业合併
    • 认证和许可

第七章主要企业简介

  • Thermo Fisher Scientific
  • F Hoffmann-La Roche
  • Merck Group
  • Corning Incorporated
  • Agilent Technologies
  • PerkinElmer
  • Illumina
  • Beckman Coulter
  • Bio-Rad Laboratories
  • Qiagen
简介目录

The future of the global nucleic acid extraction instrument and reagent market looks promising with opportunities in the academic research institute, hospitals & diagnostic centers, pharmaceutical & biotechnology, and contract research organization markets. The global nucleic acid extraction instrument and reagent market is expected to grow with a CAGR of 10.4% from 2025 to 2031. The major drivers for this market are the rising interest in customized treatment, the increase in the occurrence of chronic illnesses, and the growing development of medical diagnostics.

  • Lucintel forecasts that, within the type category, the instruments is expected to witness the highest growth.
  • Within this end use category, academic research institutes is expected to witness the highest growth.
  • In terms of regions, North America is expected to witness the highest growth.

Gain Valuable Insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Nucleic Acid Extraction Instrument and Reagent Market

The nucleic acid extraction instrument and reagent market is evolving rapidly, driven by technological advancements and increasing demand for accurate diagnostics. These emerging trends reflect the industry's response to the growing need for efficient, reliable, and scalable solutions across various applications, from clinical diagnostics to research.

  • Integration of Automation: Automation is becoming increasingly prevalent in nucleic acid extraction processes, reducing human error and increasing throughput. Automated systems enable laboratories to handle higher sample volumes with consistent results, improving efficiency and allowing for real-time monitoring of extraction protocols.
  • Miniaturization of Instruments: There is a growing trend toward the miniaturization of nucleic acid extraction instruments. Compact devices offer portability and ease of use, making them suitable for point-of-care testing and field applications. This shift enhances accessibility and reduces reagent consumption, aligning with sustainability goals.
  • Use of Magnetic Bead Technology: Magnetic bead-based extraction methods are gaining traction due to their efficiency and versatility. This technology simplifies the extraction process, enabling quicker and more effective isolation of nucleic acids while minimizing contamination risks. Its compatibility with various sample types drives widespread adoption across laboratories.
  • Focus on Cost-Effective Solutions: As demand for nucleic acid testing increases globally, there is a heightened focus on developing cost-effective extraction solutions. Manufacturers are innovating to provide affordable reagents and instruments, making high-quality nucleic acid extraction accessible to a broader range of laboratories, especially in emerging markets.
  • Emphasis on Quality Control: Quality control measures are becoming increasingly important in the nucleic acid extraction process. An enhanced focus on the standardization and validation of extraction protocols ensures reproducibility and reliability, particularly in clinical settings. This trend is vital for regulatory compliance and meeting the stringent demands of diagnostic applications.

The nucleic acid extraction market is poised for significant advancements driven by automation, miniaturization, and innovative technologies. As the demand for reliable and efficient diagnostic solutions grows, the industry is responding with cost-effective and high-quality products. These emerging trends enhance laboratory capabilities and improve accessibility for a broader range of users, including those in resource-limited settings. Ultimately, the ongoing evolution of this market will play a critical role in advancing molecular biology and clinical diagnostics, ensuring better health outcomes globally.

Recent Developments in the Nucleic Acid Extraction Instrument and Reagent Market

The nucleic acid extraction instrument and reagent market is undergoing rapid transformation, characterized by significant technological advancements and innovations. These developments enhance the efficiency, reliability, and accessibility of nucleic acid extraction methods, catering to diverse applications in research, diagnostics, and biotechnology.

  • Advancements in Automation: The integration of automated systems in nucleic acid extraction processes has revolutionized laboratory workflows. These systems minimize human error and significantly increase throughput, allowing labs to process larger sample volumes efficiently. Automation also enables real-time monitoring, ensuring consistent quality and performance across multiple runs.
  • Emergence of Integrated Solutions: There is a notable trend toward integrated platforms that combine nucleic acid extraction with downstream applications, such as PCR and sequencing. These all-in-one solutions streamline workflows, reduce sample handling steps, and enhance overall efficiency. By facilitating a seamless transition from extraction to analysis, integrated solutions are increasingly favored in both research and clinical settings.
  • Enhanced Reagent Formulations: Recent developments in reagent formulations have led to improved extraction efficiency and yield. Novel reagents are designed to optimize the binding and elution of nucleic acids, resulting in higher-quality samples. These enhancements address the needs of various applications, from clinical diagnostics to genetic research, ultimately supporting more reliable results.
  • Focus on Point-of-Care Testing: The demand for point-of-care (POC) testing has spurred innovations in nucleic acid extraction technologies. Portable and user-friendly devices are being developed to enable rapid testing in diverse settings, including remote areas. This trend addresses the urgent need for timely diagnostics, particularly in infectious disease outbreaks and resource-limited environments.
  • Sustainability Initiatives: Increasing awareness of environmental concerns is driving sustainability initiatives within the nucleic acid extraction market. Manufacturers are focusing on developing eco-friendly reagents and instruments that minimize waste and reduce environmental impact. This shift not only aligns with global sustainability goals but also appeals to laboratories striving to adopt greener practices.

The nucleic acid extraction instrument and reagent market is marked by key developments that enhance efficiency, integration, and sustainability. With advancements in automation, integrated solutions, and eco-friendly practices, the market is evolving to meet the growing demands of research and diagnostics. These innovations are critical for improving the reliability and accessibility of nucleic acid testing, ultimately contributing to better health outcomes and advancing scientific discovery. As the landscape continues to change, the industry is well-positioned for future growth and transformation.

Strategic Growth Opportunities for Nucleic Acid Extraction Instrument and Reagent Market

The nucleic acid extraction instrument and reagent market is ripe for growth, driven by advancements in technology and increasing demand for efficient diagnostic solutions. Companies can capitalize on several strategic opportunities that cater to evolving market needs and expand their reach across various sectors, including healthcare, research, and biotechnology.

  • Expansion into Emerging Markets: As healthcare infrastructure develops in emerging markets, there is growing demand for nucleic acid extraction technologies. Companies can strategically invest in these regions to offer affordable and accessible solutions tailored to local needs. Establishing partnerships with local distributors and healthcare providers can enhance market penetration and drive growth.
  • Development of Customized Solutions: Tailoring nucleic acid extraction instruments and reagents to meet specific applications and user needs presents significant growth potential. By collaborating with research institutions and clinical laboratories, manufacturers can design specialized products that cater to various sample types and extraction methods, enhancing user satisfaction and market competitiveness.
  • Integration of AI and Machine Learning: The integration of artificial intelligence (AI) and machine learning technologies into nucleic acid extraction processes offers opportunities for enhanced efficiency and accuracy. These technologies can optimize extraction protocols, improve yield, and reduce processing times, making them attractive features for modern laboratories seeking high-performance solutions.
  • Focus on Personalized Medicine: The rise of personalized medicine presents a unique opportunity for nucleic acid extraction companies. As genomics plays a crucial role in tailored therapies, the demand for high-quality nucleic acid extraction is increasing. By developing robust solutions that support genomic studies and precision medicine, companies can position themselves at the forefront of this growing market.
  • Partnerships and Collaborations: Strategic partnerships with biotech firms, academic institutions, and diagnostic companies can foster innovation and expand market reach. Collaborative efforts can facilitate the development of cutting-edge extraction technologies and broaden the application of nucleic acid testing in various fields, including cancer research, infectious disease diagnostics, and genetic studies.

The nucleic acid extraction instrument and reagent market offers numerous strategic growth opportunities, driven by technological advancements and increasing global demand. By focusing on emerging markets, customized solutions, and innovative technologies like AI, companies can position themselves for success in a competitive landscape. Additionally, collaborations and partnerships can enhance product offerings and expand market reach, ensuring that businesses are well-equipped to meet the evolving needs of healthcare and research sectors. As the market continues to evolve, seizing these opportunities will be crucial for long-term growth and innovation.

Nucleic Acid Extraction Instrument and Reagent Market Driver and Challenges

The nucleic acid extraction instrument and reagent market is influenced by various drivers that foster growth while facing several challenges that companies must navigate. Understanding these dynamics is essential for stakeholders looking to optimize their strategies and capitalize on emerging opportunities in this rapidly evolving sector.

The factors responsible for driving the nucleic acid extraction instrument and reagent market include:

  • Growing Demand for Diagnostic Testing: The increasing prevalence of genetic disorders and infectious diseases has heightened the demand for accurate diagnostic testing. This trend drives the need for reliable nucleic acid extraction technologies, as they are critical for producing high-quality samples necessary for effective testing and treatment.
  • Advancements in Biotechnology: Rapid advancements in biotechnology are propelling innovation in nucleic acid extraction methods. New technologies, such as automated systems and magnetic bead-based extraction, enhance efficiency and reliability. These innovations not only improve lab workflows but also cater to the growing needs of researchers and clinicians for high-throughput solutions.
  • Rising Investment in Genomics: The surge in investment in genomics research is driving demand for nucleic acid extraction instruments and reagents. As more institutions focus on genomics for personalized medicine and drug development, the need for advanced extraction technologies becomes increasingly crucial, presenting significant growth opportunities for market players.
  • Regulatory Support for Molecular Diagnostics: Supportive regulatory frameworks for molecular diagnostics are fostering market growth. Governments and regulatory bodies are encouraging the development and adoption of nucleic acid-based testing methods, which further stimulate demand for extraction technologies and reagents that meet stringent quality standards.
  • Increased Awareness of Personalized Medicine: The growing awareness and implementation of personalized medicine are creating a demand for advanced nucleic acid extraction solutions. As healthcare shifts towards tailored treatments based on genetic information, the need for efficient and accurate extraction methods becomes paramount, driving market expansion.

Challenges in the nucleic acid extraction instrument and reagent market are:

  • High Cost of Advanced Technologies: One significant challenge facing the nucleic acid extraction market is the high cost associated with advanced technologies and automated systems. Smaller laboratories and facilities in emerging markets may struggle to invest in these high-priced instruments, limiting their access to efficient extraction methods.
  • Regulatory Hurdles: The nucleic acid extraction market must navigate complex regulatory environments that can slow down the approval and commercialization of new products. Adhering to stringent quality and safety standards requires significant resources and time, posing challenges for companies seeking to bring innovative solutions to market quickly.
  • Competition and Market Saturation: As the demand for nucleic acid extraction technologies grows, the market is becoming increasingly competitive. Many players are entering the space, leading to potential saturation. Companies must differentiate their offerings and continuously innovate to maintain market share and address evolving customer needs.

The nucleic acid extraction instrument and reagent market presents a landscape rich with opportunities driven by technological advancements and increasing demand for diagnostic testing. While challenges such as high costs, regulatory hurdles, and competition exist, addressing these issues strategically can enable companies to thrive. By leveraging the growth drivers and navigating the challenges effectively, stakeholders can position themselves to capitalize on the evolving needs of the healthcare and research sectors, ensuring long-term success in this dynamic market.

List of Nucleic Acid Extraction Instrument and Reagent Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies nucleic acid extraction instrument and reagent companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the nucleic acid extraction instrument and reagent companies profiled in this report include-

  • Thermo Fisher Scientific
  • F Hoffmann-La Roche
  • Merck Group
  • Corning Incorporated
  • Agilent Technologies
  • PerkinElmer
  • Illumina
  • Beckman Coulter
  • Bio-Rad Laboratories
  • Qiagen

Nucleic Acid Extraction Instrument and Reagent by Segment

The study includes a forecast for the global nucleic acid extraction instrument and reagent market by type, extraction type, method, end use, and region.

Nucleic Acid Extraction Instrument and Reagent Market by Type [Analysis by Value from 2019 to 2031]:

  • Instruments
  • Spin Columns
  • Beads or Magnetic Beads
  • Automated Nucleic Acid Extraction Systems
  • Extraction Kits, Reagents & Consumables
  • Others

Nucleic Acid Extraction Instrument and Reagent Market by Extraction Type [Analysis by Value from 2019 to 2031]:

  • DNA Extraction
  • DNA or RNA Extraction
  • RNA Extraction

Nucleic Acid Extraction Instrument and Reagent Market by Method [Analysis by Value from 2019 to 2031]:

  • Solution-Based Methods
  • Solid-Phase-Based Methods

Nucleic Acid Extraction Instrument and Reagent Market by End Use [Analysis by Value from 2019 to 2031]:

  • Academic Research Institutes
  • Hospitals & Diagnostic Centers
  • Pharmaceutical & Biotechnology
  • Contract Research Organizations
  • Others

Nucleic Acid Extraction Instrument and Reagent Market by Region [Analysis by Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Nucleic Acid Extraction Instrument and Reagent Market

The nucleic acid extraction instrument and reagent market is witnessing significant growth across key regions, fueled by advancements in technology and increasing demand for efficient diagnostic solutions. In the U.S., innovations in automation are enhancing extraction processes, while China is ramping up domestic production and affordability. Germany leads with a focus on AI integration, and India is expanding through collaborations to meet diverse needs. Meanwhile, Japan's emphasis on precision and miniaturization is driving the development of compact, high-quality systems. Together, these trends reflect a dynamic and rapidly evolving landscape in the nucleic acid extraction industry.

  • U.S.: In the U.S., the nucleic acid extraction market is experiencing significant growth driven by advancements in automation and efficiency. Companies are investing in innovative technologies to enhance extraction processes, aiming to meet the increasing demand for rapid and reliable diagnostics, particularly in the context of infectious diseases.
  • China: China has seen a surge in domestic production of nucleic acid extraction instruments, supported by government initiatives to bolster biotechnology sectors. The focus on affordable, high-throughput solutions is driving competition, with local companies rapidly adopting international standards to enhance quality and reliability.
  • Germany: Germany continues to be a leader in the nucleic acid extraction market, with a strong emphasis on research and development. German manufacturers are integrating AI and machine learning into their instruments to optimize extraction protocols, ensuring higher yields and improved accuracy, thereby supporting both clinical and research applications.
  • India: In India, the nucleic acid extraction market is expanding due to increasing investment in biotechnology and healthcare infrastructure. Local firms are collaborating with international partners to enhance their product offerings, focusing on cost-effective solutions that cater to the diverse needs of hospitals and research institutions.
  • Japan: Japan is advancing in the nucleic acid extraction field through innovations in precision and miniaturization. The country's strong focus on automation and robotics in laboratory processes is leading to the development of compact, efficient extraction systems, enhancing throughput while maintaining high-quality standards for both research and clinical diagnostics.

Features of the Global Nucleic Acid Extraction Instrument and Reagent Market

Market Size Estimates: Nucleic acid extraction instrument and reagent market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Nucleic acid extraction instrument and reagent market size by various segments, such as by type, extraction type, method, end use, and region in terms of value ($B).

Regional Analysis: Nucleic acid extraction instrument and reagent market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, extraction types, methods, end uses, and regions for the nucleic acid extraction instrument and reagent market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the nucleic acid extraction instrument and reagent market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the nucleic acid extraction instrument and reagent market by type (instruments, spin columns, beads or magnetic beads, automated nucleic acid extraction systems, extraction kits, reagents & consumables, and others), extraction type (DNA extraction, DNA or RNA extraction, and RNA extraction), method (solution-based methods and solid-phase-based methods), end use (academic research institutes, hospitals & diagnostic centers, pharmaceutical & biotechnology, contract research organizations, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Nucleic Acid Extraction Instrument and Reagent Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

  • 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
  • 3.2. Global Nucleic Acid Extraction Instrument and Reagent Market Trends (2019-2024) and Forecast (2025-2031)
  • 3.3: Global Nucleic Acid Extraction Instrument and Reagent Market by Type
    • 3.3.1: Instruments
    • 3.3.2: Spin Columns
    • 3.3.3: Beads or Magnetic Beads
    • 3.3.4: Automated Nucleic Acid Extraction Systems
    • 3.3.5: Extraction Kits, Reagents & Consumables
    • 3.3.6: Others
  • 3.4: Global Nucleic Acid Extraction Instrument and Reagent Market by Extraction Type
    • 3.4.1: DNA Extraction
    • 3.4.2: DNA Or RNA Extraction
    • 3.4.3: RNA Extraction
  • 3.5: Global Nucleic Acid Extraction Instrument and Reagent Market by Method
    • 3.5.1: Solution-Based Methods
    • 3.5.2: Solid-Phase-Based Methods
  • 3.6: Global Nucleic Acid Extraction Instrument and Reagent Market by End Use
    • 3.6.1: Academic Research Institutes
    • 3.6.2: Hospitals & Diagnostic Centers
    • 3.6.3: Pharmaceutical & Biotechnology
    • 3.6.4: Contract Research Organizations
    • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

  • 4.1: Global Nucleic Acid Extraction Instrument and Reagent Market by Region
  • 4.2: North American Nucleic Acid Extraction Instrument and Reagent Market
    • 4.2.1: North American Market by Type: Instruments, Spin Columns, Beads or Magnetic Beads, Automated Nucleic Acid Extraction Systems, Extraction Kits, Reagents & Consumables, and Others
    • 4.2.2: North American Market by End Use: Academic Research Institutes, Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology, Contract Research Organizations, and Others
  • 4.3: European Nucleic Acid Extraction Instrument and Reagent Market
    • 4.3.1: European Market by Type: Instruments, Spin Columns, Beads or Magnetic Beads, Automated Nucleic Acid Extraction Systems, Extraction Kits, Reagents & Consumables, and Others
    • 4.3.2: European Market by End Use: Academic Research Institutes, Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology, Contract Research Organizations, and Others
  • 4.4: APAC Nucleic Acid Extraction Instrument and Reagent Market
    • 4.4.1: APAC Market by Type: Instruments, Spin Columns, Beads or Magnetic Beads, Automated Nucleic Acid Extraction Systems, Extraction Kits, Reagents & Consumables, and Others
    • 4.4.2: APAC Market by End Use: Academic Research Institutes, Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology, Contract Research Organizations, and Others
  • 4.5: ROW Nucleic Acid Extraction Instrument and Reagent Market
    • 4.5.1: ROW Market by Type: Instruments, Spin Columns, Beads or Magnetic Beads, Automated Nucleic Acid Extraction Systems, Extraction Kits, Reagents & Consumables, and Others
    • 4.5.2: ROW Market by End Use: Academic Research Institutes, Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology, Contract Research Organizations, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Nucleic Acid Extraction Instrument and Reagent Market by Type
    • 6.1.2: Growth Opportunities for the Global Nucleic Acid Extraction Instrument and Reagent Market by Extraction Type
    • 6.1.3: Growth Opportunities for the Global Nucleic Acid Extraction Instrument and Reagent Market by Method
    • 6.1.4: Growth Opportunities for the Global Nucleic Acid Extraction Instrument and Reagent Market by End Use
    • 6.1.5: Growth Opportunities for the Global Nucleic Acid Extraction Instrument and Reagent Market by Region
  • 6.2: Emerging Trends in the Global Nucleic Acid Extraction Instrument and Reagent Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Nucleic Acid Extraction Instrument and Reagent Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Nucleic Acid Extraction Instrument and Reagent Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: F Hoffmann-La Roche
  • 7.3: Merck Group
  • 7.4: Corning Incorporated
  • 7.5: Agilent Technologies
  • 7.6: PerkinElmer
  • 7.7: Illumina
  • 7.8: Beckman Coulter
  • 7.9: Bio-Rad Laboratories
  • 7.10: Qiagen